US Broker Ratings

Vaxcyte, Inc. (PCVX) Investor Outlook: Exploring a 280.83% Upside Potential

Investors with a keen interest in the biotechnology sector may find Vaxcyte, Inc. (NASDAQ: PCVX) an intriguing prospect. With its current market capitalization standing at $4.26 billion, Vaxcyte is positioned..

ADMA Biologics Inc (ADMA)

⚠️ No article content returned.

..

Waters Corporation (WAT): Analyst Ratings Show Potential 28.82% Upside — What Investors Need to Know

Waters Corporation (NYSE: WAT), a leading player in the healthcare sector’s diagnostics and research industry, is drawing attention from investors with its strategic market positioning and promising growth prospects. Headquartered..

Novartis AG (NVS) Stock Analysis: Navigating Growth with a Strong Dividend Yield and Robust Revenue Expansion

Novartis AG (NVS), a heavyweight in the healthcare sector, stands as a formidable player in the global pharmaceutical market. Headquartered in Basel, Switzerland, the company is renowned for its innovative..

Solventum Corporation (SOLV) Investor Outlook: Examining a Promising 18.3% Potential Upside

Solventum Corporation (NYSE: SOLV), a prominent player in the healthcare sector, offers a diverse portfolio of medical solutions that serve both consumer and professional markets. With a market capitalization of..

Humana Inc. (HUM) Stock Analysis: Potential 17% Upside Amid Healthcare Sector Dynamics

Humana Inc. (NYSE: HUM), a formidable player in the healthcare sector, offers a compelling case for investors seeking exposure to the healthcare plans industry. With a market capitalization of $29.74..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Navigating Growth in Healthcare with a 14.20% Revenue Surge

Medpace Holdings, Inc. (NASDAQ: MEDP) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. Based in Cincinnati, Ohio, and operating across North America,..

UnitedHealth Group (UNH) Stock Analysis: Exploring a Potential 40.87% Upside

UnitedHealth Group Incorporated (NYSE: UNH), a leader in the healthcare sector, has long been a staple for investors seeking stability and growth. As a diversified healthcare company, UnitedHealth operates through..

Stevanato Group S.p.A. (STVN) Stock Analysis: Navigating Growth in the Healthcare Sector with 11.36% Upside Potential

Stevanato Group S.p.A. (NYSE: STVN) presents a compelling opportunity for investors interested in the healthcare sector. With a market capitalization of $6.86 billion, Stevanato is a robust player in the..

Option Care Health, Inc. (OPCH) Stock Analysis: A 37% Upside Potential in Healthcare

Option Care Health, Inc. (NASDAQ: OPCH), a leading provider of home and alternate site infusion services, is attracting significant attention from investors, thanks to its robust growth potential and strong..

STERIS plc (STE) Stock Analysis: Exploring a Promising 18% Upside for Investors

STERIS plc (NYSE: STE), a key player in the healthcare sector specializing in medical devices, presents an intriguing opportunity for investors. With a market capitalization of $22.32 billion, STERIS is..

DexCom, Inc. (DXCM) Stock Analysis: Impressive 28.76% Upside with Strong Buy Ratings

DexCom, Inc. (NASDAQ: DXCM), a leading player in the healthcare sector, specializes in the medical devices industry, focusing on continuous glucose monitoring (CGM) systems. With a market capitalization of $31.09..

Mettler-Toledo International (MTD): Investor Outlook Reveals 6.61% Potential Upside

Mettler-Toledo International, Inc. (NYSE: MTD) is a formidable player in the diagnostics and research sector within the healthcare industry. The company, with a substantial market cap of $24.88 billion, is..

Bio-Techne Corp (TECH) Investor Outlook: Exploring a 21% Potential Upside and Robust Buy Ratings

Bio-Techne Corporation (NASDAQ: TECH), a key player in the biotechnology sector, presents a compelling case for investors with a significant potential upside of 21.15%. Headquartered in Minneapolis, Minnesota, the company..

RadNet, Inc. (RDNT) Stock Analysis: A 30.87% Potential Upside Amid Strong Buy Ratings

RadNet, Inc. (NASDAQ: RDNT), a key player in the healthcare sector, specifically within the diagnostics and research industry, presents a compelling case for investors seeking growth opportunities in the medical..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Unveiling a 26.12% Potential Upside

Summit Therapeutics Inc. (SMMT) stands as a noteworthy player in the biotechnology industry, commanding attention with its $20.1 billion market capitalization. The company, headquartered in Miami, Florida, is making waves..

Walgreens Boots Alliance, Inc. (WBA) Stock Analysis: Evaluating Growth Prospects Amid an 8.59% Dividend Yield

Walgreens Boots Alliance, Inc. (NASDAQ: WBA), a stalwart in the pharmaceutical retail industry, is drawing investor attention with its notable 8.59% dividend yield, a significant figure in today’s yield-hungry market...

Alkermes plc (ALKS) Investor Outlook: Analyzing the 56% Upside Potential in the Biopharmaceutical Space

For investors looking to explore opportunities in the healthcare sector, Alkermes plc (NASDAQ: ALKS) presents a compelling case with a potential upside of 56.31%. This Irish-based biopharmaceutical company has carved..

Halozyme Therapeutics (HALO) Stock Analysis: A Biotech Powerhouse with 11.64% Potential Upside

Halozyme Therapeutics, Inc. (NASDAQ: HALO) has carved a significant niche in the biotechnology sector, leveraging its proprietary enzyme technology to transform the delivery and efficacy of injectable therapeutics. With a..

Fresenius Medical Care AG (FMS) Stock Analysis: Insight into Potential 25% Upside for Investors

Fresenius Medical Care AG (FMS), a global leader in providing dialysis and related services, continues to captivate investor interest with a promising potential upside of 25.24%. Operating primarily in the..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds